Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based StudyEffects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study
- Other Titles
- Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study
- Authors
- 고지원; 김준강; 조혜민; 하용찬; 김태영; 이영균; 김하영; 장선미
- Issue Date
- Sep-2020
- Publisher
- 대한내분비학회
- Keywords
- Glucocorticoids; Fracture; Epidemiologic studies; Osteoporosis
- Citation
- ENDOCRINOLOGY AND METABOLISM, v.35, no.3, pp.562 - 570
- Journal Title
- ENDOCRINOLOGY AND METABOLISM
- Volume
- 35
- Number
- 3
- Start Page
- 562
- End Page
- 570
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79409
- DOI
- 10.3803/EnM.2020.659
- ISSN
- 2093-596X
- Abstract
- Background: Long-term glucocorticoid use increases fracture risk by reducing bone mass. This study evaluated the relationship between hip and vertebral fractures and the total amount of systematic glucocorticoid use.
Methods: We randomly selected 1,896,159 people aged 20 to 100 years who participated in the National Health Checkup programin 2006. The amount of glucocorticoids prescribed was calculated based on the defined daily dose (DDD). The total DDD was obtained by adding oral and parenteral glucocorticoids for 6 months from the index date. Subjects were categorized into four groupsaccording to total glucocorticoid DDDs: non-users (DDDs=0), low users (0< DDDs ≤45), intermediate users (45< DDDs ≤90),and high users (90< DDDs). We followed them for 2 years. A multivariate Cox proportional hazard model was used to evaluate theeffects of the total amount of glucocorticoid use on hip and vertebral fractures.
Results: Higher glucocorticoid use was associated with a higher risk of vertebral fracture. Relative to non-users, the vertebral fracturerisk was 1.39 times higher in the low-user group, 1.94 times higher in the intermediate-user group, and 2.43 times higher in the highuser group. The risk of hip fracture was 1.72 times higher in intermediate users and 3.28 times higher in high users than in non-users.
Conclusion: As the amount of glucocorticoid use for 6 months increased, the risk of hip and vertebral fractures became higher. Inorder to prevent fractures, it is necessary for doctors to evaluate the total amount of glucocorticoid prescribed to the patient and toprovide appropriate treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79409)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.